ReEmerge, Inc. exited stealth with an oversubscribed $37M Series A to address chronic cognitive impairment caused by brain injuries.
ReEmerge is a MedTech company innovating cognitive impairment treatment, focusing on restoring cognitive function through deep brain stimulation
ReEmerge is a MedTech company innovating cognitive impairment treatment, focusing on restoring cognitive function through deep brain stimulation. It aims to address chronic cognitive impairment caused by traumatic brain injuries through its proprietary Cognitive Network Restoration Therapy (CNRT).